Pictet Asset Management (Switzerland)’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-771,110	Closed	-$18.6M	–	2063
2023 Q1	$18.6M	Buy	771,110 +760,089	+6,897%	+$9.54M	0.02%	477
2022 Q4	$116K	Buy	+11,021	New	+$88.9K	﹤0.01%	1836

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s PRVB Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 771,110 shares — an estimated $18.6M sold.

Pictet Asset Management (Switzerland) first reported a position in PRVB in Q4 2022 and held it in 2 quarters. The position peaked at $18.6M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Pictet Asset Management (Switzerland) reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Pictet Asset Management (Switzerland) sold 771,110 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $18.6M.
Pictet Asset Management (Switzerland) first reported a position in Provention Bio, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
Pictet Asset Management (Switzerland)'s Provention Bio, Inc. Common Stock position peaked at $18.6M in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.